Keiser Wilhelms gate 24
Ålesund 6003
Norway
47 73 10 22 00
https://www.hofsethbiocare.com
Settore/i:
Settore:
Impiegati a tempo pieno: 69
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Jon Olav Odegard | Chief Executive Officer | 2,84M | N/D | N/D |
Ms. Christel Elise Kanli | CFO & COO | 1,45M | N/D | N/D |
Dr. Bomi Framroze | Chief Scientific Officer | 9,44M | N/D | 1961 |
Mr. James Berger | Chief Commercial Officer | 501k | N/D | N/D |
Ms. Angelika Florvaag | Chief Quality Officer | 1,26M | N/D | N/D |
Dr. Crawford Linden Alexander Currie | Head of Medical R&D and Director | 96k | N/D | N/D |
Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States. The company's products include OmeGo, a salmon oil, which offers the full spectrum of fatty acids and omegas found naturally in fresh whole salmon; ProGo, a bioactive peptide for VMS, metabolism and active nutrition needs; CalGo, an absorbable complex mineral for bone and joint health; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was incorporated in 2000 and is headquartered in Ålesund, Norway.
L'ISS Governance QualityScore di Hofseth BioCare ASA al 1 maggio 2024 è 10. I criteri di valutazione fondamentali sono revisione: 10; Consiglio di Amministrazione: 9; diritti degli azionisti: 10; retribuzione: 10.